Elevated prolactin in pediatric patients on typical and atypical antipsychotics

Journal of Child and Adolescent Psychopharmacology

Volumn 9, Issue 4, 1999, Pages 239-245

  Wudarsky, Marianne ^a   Nicolson, Rob ^a   Hamburger, Susan D ^a   Spechler, Lori ^a   Gochman, Peter ^a   Bedwell, Jeffrey ^a   Lenane, Marge C ^a   Rapoport, Judith L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; HYPERPROLACTINEMIA; MALE; PROLACTIN BLOOD LEVEL; RISK ASSESSMENT; SCHIZOPHRENIA; SCHOOL CHILD;

EID: 0033405513     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1999.9.239     Document Type: Article

References (23)

1. Abbott: AXSYM System, Prolactin: package insert. Abbott Laboratories Diagnostics Division, April 1997
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC, American Psychiatric Press, 1987
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Press, 1994
4. Crawford AM, Beasley CM, Tollefson GD: The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res 26:41-54, 1997
5. Dickson RA, Glazer WM: Neuroleptic-induced hyperprolactinemia. Schizophr Res 35:S75-S86, 1999
6. Dufour DR: Reference values in endocrinology. In: Principles and Practice of Endocrinology and Metabolism. Edited by Becker KL. Philadelphia, Lippincott, 1995, pp 1992-1993
7. Frazier JA, Gordon CT, McKenna K, Lenane MC, Jih D, Rapoport JL: An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 33:658-663, 1994
8. Freisen HG, Ezrin C, Godden J: Clinical Endocrinology: A Survey of Current Practice. New York, Appleton-Century-Crofts, 1977
9. Grumbach M, Styne D: Puberty: ontogeny, neuroendocrinology, physiology and disorders. In: Williams Textbook of Endocrinology, 9th ed. Edited by: Wilson JD, Foster DW, Kronenberg HM, Larsen PR. Philadelphia, Saunders, 1998, p 1528
10. Henry JM, Filburn CR, Joseph JA, Roth GS: Effect of aging on striatal dopamine receptor subtypes in Wistar rats. Neurobiol Aging 7:357-361, 1986
11. Kleinberg DL, Davis JM, DeCoster R, Van Baelen B, Brecher M: Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 19:57-61, 1999
12. Kumra S, Frazier LA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, Hamburger SD, Smith AK, Albus KE, Alaghband-Rad J, Rapoport JL: Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 53:1090-1097, 1996
13. Kumra S, Jacobsen LK, Lenane MC, Zahn TP, Wiggs E, Alaghband-Rad J, Castellanos FX, Frazier JA, McKenna K, Gordon CT, Smith A, Hamburger SD, Rapoport JL: "Multidimensionally impaired disorder": Is it a variant of very early onset of schizophrenia? J Am Acad Child Adolesc Psychiatry 37:91-99, 1998a
14. Kumra S, Jacobsen LK, Lenane MC, Smith A, Lee P, Malanga CJ, Karp BI, Hamburger SD, Rapoport JL: Case series: Spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 37:221-227, 1998b
15. Kumra S, Jacobsen LK, Kenane MC, Karp BI, Frazier JA, Smith AK, Bedwell J, Lee P, Malanga CJ, Hamburger SD, Rapoport JL: Childhood onset schizophrenia: An open-label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry 37:377-385, 1998c
16. McKenna K, Gordon CT, Lenane MC, Kaysen D, Fahey K, Rapoport JL: Looking for childhood-onset schizophrenia: The first 71 cases screened. J Am Acad Child Adolesc Psychiatry 33:636-644, 1994
17. Meltzer HY, Goode DJ, Schyve PM, Young M, Fang VS: Effect of clozapine on human serum prolactin levels. Am J Psychiatry 136:1550-1555, 1979
18. Rubin RT: Prolactin and schizophrenia. In: Psychopharmacology: The Third Generation of Progress. Edited by Meltzer, HY. New York, Raven Press, 1987, pp 803-808
19. Santoni JP, Saubadu S: Adverse events associated with neuroleptic drugs: Focus on neuroendocrine reactions. Acta Ther 31:193-204, 1995
20. Seeman P, Bzowej NH, Guan H-C, Bergeron C, Becker LE, Reynolds GP, Bird ED, Reiderer P, Jellinger K, Watanabe S, Toutelotte WW: Human brain dopamine receptors in children and aging adults. Synapse 1:399-404, 1987
21. Sikich L, Williamson K, Malekpour A, Bashford R, Hooper S, Sheitman B, Lieberman J: Double-blind comparison of haloperidol, risperidone and olanzapine in psychotic youth. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 1999
22. Thorner MO, Vance ML, Laws ER, Horvath E, Kovacs K: The anterior pituitary. In: Williams Textbook of Endocrinology, 9th ed. Edited by Wilson JD, Foster DW, Kronenberg HM, Larsen PR. Philadelphia, Saunders 1998, pp 249-340
23. Wesselmann U, Windgassen K: Galactorrhea: subjective response by schizophrenic patients. Acta Psychiatr Scand 95:152-155, 1995